Description
This dual-compound formulation combines the pentadecapeptide BPC-157 with the synthetic thymosin beta-4 derivative TB-500. This specific blend has been researched to prove to exhibit synergistic effects on cellular regeneration pathways in laboratory models. While BPC-157 is observed to modulate inflammatory cytokines and stimulate angiogenesis (blood vessel formation), TB-500 is documented to upregulate actin polymerization, a process essential for cell migration and cytoskeletal structure. Research often focuses on the concurrent application of these peptides to investigate accelerated repair mechanisms in dense connective tissues, such as tendons and ligaments, exceeding the theoretical efficacy of individual application.
Ingredients
-
Active Agents: BPC-157 (Pentadecapeptide) & TB-500 (Thymosin Beta-4 Analog)
-
Format: Sterile Lyophilized Powder (requires reconstitution)
-
Ratio: Customary Research Blend (typically 1:1 or specific molar ratio)
-
Purity: ≥99% (HPLC Verified for both compounds)
